메뉴 건너뛰기




Volumn 43, Issue 5, 2014, Pages 301-305

Helicobacter pylori eradication - an update on the latest therapies

Author keywords

Disease eradication; Helicobacter pylori

Indexed keywords

ANTIINFECTIVE AGENT; PROTON PUMP INHIBITOR;

EID: 84900507165     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (10)

References (22)
  • 2
    • 0033606778 scopus 로고    scopus 로고
    • Effectiveness of Helicobacter pylori therapies in a clinical practice setting
    • Fennerty M, Lieberman D, Vakil N, et al. Effectiveness of Helicobacter pylori therapies in a clinical practice setting. Arch Intern Med 1999;159:1562-66.
    • (1999) Arch Intern Med , vol.159 , pp. 1562-1566
    • Fennerty, M.1    Lieberman, D.2    Vakil, N.3
  • 3
    • 84920247287 scopus 로고
    • Unidentified curved bacilli on gastric epithelium in active chronic gastritis
    • Warren J, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1:1273-75.
    • (1983) Lancet , vol.1 , pp. 1273-1275
    • Warren, J.1    Marshall, B.2
  • 5
    • 0032212505 scopus 로고    scopus 로고
    • Helicobacter pylori: rational management options
    • Peura D. Helicobacter pylori: rational management options. Am J Med 1998;105:424-30.
    • (1998) Am J Med , vol.105 , pp. 424-430
    • Peura, D.1
  • 6
    • 53749093847 scopus 로고    scopus 로고
    • Helicobacter pylori: the latest in diagnosis and treatment
    • Stenstroem B, Mendis A, Marshall B. Helicobacter pylori: the latest in diagnosis and treatment. Aust Fam Physician 2008;37:608-12.
    • (2008) Aust Fam Physician , vol.37 , pp. 608-612
    • Stenstroem, B.1    Mendis, A.2    Marshall, B.3
  • 7
    • 27744571011 scopus 로고    scopus 로고
    • Guidelines for the management of dyspepsia
    • Talley N, Vakil N. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005;100:2324-37.
    • (2005) Am J Gastroenterol , vol.100 , pp. 2324-2337
    • Talley, N.1    Vakil, N.2
  • 8
    • 34247844165 scopus 로고    scopus 로고
    • Current concepts in the management of helicobacter pylori infection: the Maastricht III Consensus Report
    • Malfertheiner P, Megraud F, O'Morain C, et al. Current concepts in the management of helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81.
    • (2007) Gut , vol.56 , pp. 772-781
    • Malfertheiner, P.1    Megraud, F.2    O'Morain, C.3
  • 9
    • 84900499468 scopus 로고    scopus 로고
    • Eradication of Helicobacter pylori and ulcer healing
    • Antibiotic Expert Group. Melbourne. Therapeutic Guidelines Ltd. [Accessed 15 March 2013].
    • Antibiotic Expert Group. Eradication of Helicobacter pylori and ulcer healing In: eTG Complete [Internet] Melbourne. Therapeutic Guidelines Ltd. 2013. Available at www.tg.org.au [Accessed 15 March 2013].
    • (2013) eTG Complete [Internet]
  • 10
    • 34547619783 scopus 로고    scopus 로고
    • American College of Gastroenterology guidelines on the management of Helicobacter pylori infection
    • Chey W, Wong B. American College of Gastroenterology guidelines on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-25.
    • (2007) Am J Gastroenterol , vol.102 , pp. 1808-1825
    • Chey, W.1    Wong, B.2
  • 11
    • 0033634852 scopus 로고    scopus 로고
    • Esomeprazolebased Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials
    • Laine L, Fennerty M, Osato M, et al. Esomeprazolebased Helicobacter pylori eradication therapy and the effect of antibiotic resistance: results of three US multicenter, double-blind trials. Am J Gastroenterol 2000;95:3393-98.
    • (2000) Am J Gastroenterol , vol.95 , pp. 3393-3398
    • Laine, L.1    Fennerty, M.2    Osato, M.3
  • 12
    • 3142696806 scopus 로고    scopus 로고
    • Seven day therapy for Helicobacter pylori in the United States
    • Vakil N, Lanza F, Schwartz H, Barth J. Seven day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther 2004;20:99-107.
    • (2004) Aliment Pharmacol Ther , vol.20 , pp. 99-107
    • Vakil, N.1    Lanza, F.2    Schwartz, H.3    Barth, J.4
  • 13
    • 84868098723 scopus 로고    scopus 로고
    • Comparison of the eradication rate between 1-week and 2-week bismuth-containing quadruple rescue therapies for Helicobacter pylori eradication
    • Yoon J, Baik G, Kim Y, et al. Comparison of the eradication rate between 1-week and 2-week bismuth-containing quadruple rescue therapies for Helicobacter pylori eradication. Gut Liver 2012;6:434-39.
    • (2012) Gut Liver , vol.6 , pp. 434-439
    • Yoon, J.1    Baik, G.2    Kim, Y.3
  • 14
    • 0030731496 scopus 로고    scopus 로고
    • What other regimens are under investigation to treat Helicobacter pylori infection?
    • Unge P. What other regimens are under investigation to treat Helicobacter pylori infection? Gastroenterol 1997;113:131-48.
    • (1997) Gastroenterol , vol.113 , pp. 131-148
    • Unge, P.1
  • 15
    • 0039862242 scopus 로고    scopus 로고
    • Eradicating Helicobacter pylori: what is the latest recommended therapy?
    • Edwards P. Eradicating Helicobacter pylori: what is the latest recommended therapy? Curr Ther 1996;Jan:49-54.
    • (1996) Curr Ther , vol.JAN , pp. 49-54
    • Edwards, P.1
  • 17
    • 85101728276 scopus 로고    scopus 로고
    • Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicenter, open-label, randomised trial
    • Liou J, Chen C, Chen M, et al. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicenter, open-label, randomised trial. Lancet 2013;381:205-13.
    • (2013) Lancet , vol.381 , pp. 205-213
    • Liou, J.1    Chen, C.2    Chen, M.3
  • 19
    • 33646185810 scopus 로고    scopus 로고
    • Second-line treatment for Helicobacter pylori eradication after sequential therapy failure: a pilot study
    • Zullo A, Francesco V, Hassan C, Panella C, Morini S, Ierardi E. Second-line treatment for Helicobacter pylori eradication after sequential therapy failure: a pilot study. Future Med 2006;3:251-54.
    • (2006) Future Med , vol.3 , pp. 251-254
    • Zullo, A.1    Francesco, V.2    Hassan, C.3    Panella, C.4    Morini, S.5    Ierardi, E.6
  • 20
    • 67349145247 scopus 로고    scopus 로고
    • Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication
    • Di Caro S, Franceeschi F, Mariani A, et al. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication. Dig Liver Dis 2009;41:480-85.
    • (2009) Dig Liver Dis , vol.41 , pp. 480-485
    • Di Caro, S.1    Franceeschi, F.2    Mariani, A.3
  • 21
    • 84900468659 scopus 로고    scopus 로고
    • Micomedix 2.0. [updated 13 March 2013] [Accessed 26 March 2013].
    • Micomedix 2.0. 2013 [updated 13 March 2013] Available at: http://healthcare.thomsonreuters.com/micromedexMobile/[Accessed 26 March 2013].
    • (2013)
  • 22
    • 0004134409 scopus 로고    scopus 로고
    • Adelaide: Pharmaceutical Society of Australia
    • Australian Medicines Handbook. Adelaide: Pharmaceutical Society of Australia; 2010.
    • (2010) Australian Medicines Handbook


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.